NFA
MDGL icon

Nationwide Fund Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Nationwide Fund Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,065
Closed -$93K – 1223
2017
Q3 		$93K Hold
2,065
– – ﹤0.01% 2927
2017
Q2 		$34K Buy
+2,065
New +$32.3K ﹤0.01% 3084
2016
Q2 		– Sell
-1,668
Closed -$14K – 3288
2016
Q1 		$14K Hold
1,668
– – ﹤0.01% 3122
2015
Q4 		$21K Hold
1,668
– – ﹤0.01% 3076
2015
Q3 		$102K Hold
1,668
– – ﹤0.01% 2890
2015
Q2 		$130K Buy
1,668
+296
+22% +$24.8K ﹤0.01% 2927
2015
Q1 		$93K Sell
1,372
-67
-5% -$5.75K ﹤0.01% 2979
2014
Q4 		$133K Buy
1,439
+21
+1% +$2.17K ﹤0.01% 2824
2014
Q3 		$149K Buy
1,418
+155
+12% +$21.6K ﹤0.01% 2835
2014
Q2 		$181K Buy
1,263
+166
+15% +$24.3K ﹤0.01% 2803
2014
Q1 		$165K Hold
1,097
– – ﹤0.01% 2574
2013
Q4 		$201K Buy
1,097
+178
+19% +$32.6K ﹤0.01% 2688
2013
Q3 		$203K Buy
919
+42
+5% +$8.94K ﹤0.01% 2651
2013
Q2 		$153K Buy
+877
New +$229K ﹤0.01% 2616

Other funds holding MDGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Nationwide Fund Advisors's MDGL Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2017, closing a stake of 2,065 shares — an estimated $93K sold.

Nationwide Fund Advisors first reported a position in MDGL in Q2 2013 and held it in 14 quarters. The position peaked at $203K in Q3 2013. 91 funds tracked by Wall St. Rank hold MDGL as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Madrigal Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 2,065 Madrigal Pharmaceuticals shares in Q4 2017, an estimated $93K.
  • Nationwide Fund Advisors first reported a position in Madrigal Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Nationwide Fund Advisors's Madrigal Pharmaceuticals position peaked at $203K in Q3 2013.
  • 91 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.